Beverly Van Houten’s sister died from ovarian cancer in 2005, just six months after her diagnosis at stage IV. Capitol Ovarian Cancer Organization (COCO) was founded in August of 2007. As Beverly recalls, “My friends and I got together and decided that we wanted to form an organization especially for the awareness part. We just … Continued
02/22/2012 Research by a team of scientists funded by OCRF has shown that there is an association between invasive ovarian cancer and endometriosis. The research was reported on February 22nd in Lancet Oncology. The Ovarian Cancer Association Consortium, a collaborative created with the support of OCRF and led by grantee Dr. Andrew Berchuck, conducted an analysis … Continued
02/17/2012 An international team of researchers led by OCRF grantee Anil Sood, MD has found that elevated platelet levels in ovarian cancer patients fuel tumor growth and reduce survival. These findings reveal a new factor in cancer progression and a possible new approach for treatment. The study, which was reported in the New England Journal of Medicine, was … Continued
02/16/2012 Work funded by Ovarian Cancer Research Fund has shown that the high-grade serous ovarian cancer arises in the fallopian tube of mice that lack two specific genes. The report appeared online this week in the journal Proceedings of the National Academy of Sciences. Little is known about how ovarian cancer starts and spreads. Recent … Continued
2012 marks the 10th anniversary of St. Louis Ovarian Cancer Awareness (SLOCA), a Partner Member dedicated to raising awareness, funding ovarian cancer research and supporting women with the disease in the greater St. Louis area. The group’s founder, Christina Carr, was an ovarian cancer survivor who wanted to be sure other women knew about this … Continued
01/27/2012 A large, multicenter study shows that women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes have better survival rates than women who do not have such mutations. The study is also the first to provide strong evidence that ovarian cancer prognosis is better for women with BRCA2 mutations than … Continued
01/24/2012 The use of symptom indices to identify patients with symptoms associated with ovarian cancer who may need further screening is increasing in both the UK and the US in an attempt to promote earlier diagnosis, but these indices may need to be reassessed in order to help better detect cancer, according to a study … Continued
01/20/2012 Dr. Doug Levine and Dr. Carol Aghajanian, both recipients of OCRF grants, were part of a project recently published in Cancer Discovery that studied AKT inhibition in ovarian cancer cell lines with various mechanisms of AKT pathway activation. Researchers found that some cell lines were responsive to AKT inhibitors, but depended greatly on other, co-existent, … Continued
OCRF has awarded $5.4 million in grants for ovarian cancer research this year. After receiving over 100 applications – the highest number in its history – OCRF and its prestigious Scientific Advisory Committee endeavored first and foremost to fund the best science. The Committee evaluated each proposal through intensive peer review, and selected a sound … Continued
OCRF receives record number of grant applications; continues to fund the best science New York, NY January 3, 2012— Ovarian Cancer Research Fund (OCRF) has awarded $5.4 million in grants for ovarian cancer research this year. After receiving over 100 applications – the highest number in its history – OCRF and its prestigious Scientific Advisory … Continued
In the late 1990s, Sue Friedman was diagnosed with breast cancer. She learned that she carried a mutation in the BRCA gene that made her more likely to develop both breast and ovarian cancers. Sue felt that none of the existing breast and ovarian cancer groups met the needs of women at high risk for … Continued
Ovar’Coming Together has the distinction of being both a Partner Member and a founding member of the Ovarian Cancer National Alliance. Based in Indianapolis, the organization was founded in 1995 by three women who were going through chemotherapy at the same time. “Kai Binford, Pam Faerber and Nancy Hines created Ovar’Coming Together when they realized … Continued
Get email updates about research news, action alerts, and ways to join the fight.
